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Abstract
Aspernidine A is a prenylated isoindolinone alkaloid isolated from the model fungus Aspergillus
nidulans. A genome-wide kinase knock out library of A. nidulans was examined and it was found
that a mitogen-activated protein kinase gene, mpkA, deletion strain produces aspernidine A.
Targeted gene deletions were performed in the kinase deletion background to identify the gene
cluster for aspernidine A biosynthesis. Intermediates were isolated from mutant strains which
provided information about the aspernidine A biosynthesis pathway.
Secondary metabolites (SMs) that filamentous fungi produce have served as a valuable
source of low molecular weight molecules with a variety of biological activities. Many of
the bioactive SMs that are easily accessible under conventional laboratory conditions have
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already been isolated and patented for drug development. However, advances in genome
sequencing revealed that there is an abundance of potential SM gene clusters that have yet to
be associated with their final metabolites.1–3
One major group of SMs is polyketides (PKs) whose core structure is furnished by
polyketide synthases (PKSs). Using a variety of genome mining methods, we and others
have successfully identified the immediate products of all 14 nonreducing (NR)-PKSs in the
model fungus A. nidulans.4–9 However, for several of these NR-PKSs in A. nidulans, the
final, downstream metabolites remain unknown. We are interested in using this information
to comprehensively link metabolites to genes and to elucidate their biosynthetic pathways.
One such metabolite of interest is aspernidine A. Aspernidine A was discovered previously
by the Hertweck group by screening 45 different culture conditions using the A. nidulans
AXB4A2 strain (see Supplementary Table S2 for genotype) and was isolated from 14 L of
malt medium cultured for 7 days.10 The aromatic group in this compound suggested that its
biosynthesis is initiated by an NR-PKS. Prior to this study, our group had not been able to
detect the production of aspernidine A in the genome-sequenced strain A. nidulans FGSC
A4 and all other FGSC A4 background mutant strains. A chief requirement for the
elucidation of the genetic biosynthetic basis of SMs is the availability of a strain that
expresses the required gene cluster to yield enough material for chemical and biological
characterization. We have recently obtained and screened a genome-wide kinase knock-out
(KO) library, a resource provided by the Fungal Genetics Stock Center (FGSC) to the
Aspergillus research community,11 with the expectation that manipulating the expression of
kinases, which are key players in many aspects of regulation and signal transduction, would
be a novel approach for activating cryptic gene clusters. Through screening of this library (a
total of 98 kinase KO strains), we found one strain (mpkAΔ) that consistently produced
compounds 8 and 9 which were distinctly different from the compounds produced by the
control strain (1–7) (Figure 1A). Compound 8 was isolated from this strain from yeast agar
glucose (YAG) medium at a titer of almost 15 mg/L and identified as aspernidine A. MpkA
is one of four mitogen-activated protein kinase (MAPK) genes that the A. nidulans genome
harbors.12–17 The kinase has been shown to play a pivotal role in cell wall integrity
signalling as well as in regulation of germination of conidial spores and polarized
growth.18,19 The discovery of a strain of A. nidulans that produces aspernidine A (8) in high
titer allowed us to identify and analyze the gene cluster involved in its biosynthesis. Herein
we report the identification of the biosynthetic gene cluster for aspernidine A biosynthesis
through a series of targeted gene deletions in the mpkA background. We isolated and
characterized 3 novel related compounds, aspernidine C-E (9–11), allowing us to propose a
biosynthesis pathway for aspernidine A.
For full characterization of compound 8, the mpkAΔ strain was cultivated at a larger scale
and the target compound was purified using flash chromatography and preparative
HPLC. 1H and 13C NMR analysis identified 8 as aspernidine A.10 Additionally, a potentially
new metabolite 9 was isolated, and the similarity of UV spectra and MS fragmentation
patterns (Supplementary Figure S1) suggested it was structurally related to 8. Compound 9
had a molecular formula of C25H35NO4 (deduced from HRESI-MS), suggesting the
presence of an additional methyl group. This was confirmed by one- and two-dimensional
NMR spectroscopy (Supplementary Figures S2, S3). Though several isoindoline derivatives
have been identified from fungi, compound 9 appears to be a new compound, which we
named aspernidine C.
The chemical structure of aspernidine A led us to hypothesize that it might be derived from
orsellinaldehyde, which was shown previously to be the product of the NR-PKS, PkfA.4 To
test this hypothesis, we generated a pkfA deletion in the mpkAΔ background, replacing
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pkfA with the A. fumigatus pyroA gene, a nutritional selection marker required for
pyridoxine biosynthesis. The deletion was verified by diagnostic PCR. We cultured this
mpkAΔ, pkfAΔ double mutant and the mpkAΔ strain under the same conditions that
yielded aspernidine A. In the double mutant, aspernidine A production was eliminated
(Figure 1A). This confirmed that PkfA, the PKS encoded by pkfA, is required for the
biosynthesis of aspernidine A.
We next set out to identify additional genes involved in aspernidine A biosynthesis. Taking
advantage of the fact that secondary metabolism genes in A. nidulans are usually clustered,
we focused on the genes surrounding pkfA (Table 1, Figure 2A). We performed gene
deletions in the mpkAΔ background, and all deletions were verified by diagnostic PCR.
Again, all strains were cultivated in the same culture conditions that yielded aspernidine A.
LC/MS analysis of the extracts from the gene deletion strains showed elimination of
aspernidine A in deletants of genes from AN3225 through AN3230 (Figure 2B). The
putative functions of the genes within the cluster along with the genes immediately outside
are shown in Table 1. Deletants of AN3224 and AN3231 continued to produce aspernidine
A, indicating that we have identified the boundaries of the gene cluster. We now designate
the genes surrounding pkfA as pkfB- pkfF.
In silico analysis was carried out using the Aspergillus 16-way comparative database
asp2_v7 provided through the Aspergillus Genome Database (AspGD, http://
www.aspgd.org/) to compare the surrounding genes of this proposed gene cluster with those
of other fungal species. Interestingly, this analysis shows that our proposed aspernidine A
gene cluster is present as an insertion of ~20kb in A. nidulans within a highly conserved
region of the Aspergillus genome (Supplementary Figure S8). Furthermore, Anderson et al.
developed an algorithm to accurately predict SM gene clusters based on an annotated
genome sequence and a catalog of gene expression.20 Using this algorithm, they predicted
the number of genes in the cluster for pkfA to be six, which matches our findings from
targeted gene deletions. These data further suggest that we have correctly determined the
extent of the gene cluster responsible for the biosynthesis of aspernidine A.
The deletant strains in which aspernidine A production was eliminated were examined for
intermediates or shunt products that are part of the biosynthetic process for aspernidine A
(Figure 2B). Extracts from strains carrying deletions of pkfC, pkfD, pkfE, and pkfA showed
no obvious intermediates. Strains carrying deletions of pkfB and pkfF each displayed a
significant new peak in the chromatogram. Both strains were cultured at a larger scale and
the metabolites were isolated by flash chromatography and preparative HPLC. The
structures of compounds 10 and 11, which we have named aspernidine D and E, respectively
(Figure 1B), were determined using both one- and two-dimensional NMR spectroscopy (see
Supporting Information for detailed structural characterization, Supplementary Figures S4–
S7).
Our gene deletion data and the intermediates we isolated and structurally characterized by
NMR allow us to propose a biosynthetic pathway for aspernidine A (Scheme 1). The starting
point is the production of orsellinaldehyde by the NR-PKS PkfA as shown previously.4
Although we were unable to identify the immediate products after polyketide biosynthesis,
isolation of compound 10 from the mpkAΔ, pkfBΔ strain led us to propose that
hydroxylation, methylation of one of the phenol groups, and prenylation, presumably
catalyzed by the gene product of pkfE, a prenyltransferase gene, would be needed to yield
aspernidine D (10). Subsequently, the gene product of the cytochrome P450 monooxygenase
gene pkfB is responsible for hydroxylation of aspernidine D (10) to yield aspernidine E (11).
An aromatic dialdehyde, asperugin A, was found as a metabolic product of A. rugulosus, a
species closely related to A. nidulans.21 This compound shows structural relation to the
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aspernidines,10 leading us to hypothesize that the choline dehydrogenase gene pkfF may be
responsible for further oxidation of aspernidine E (11), to form this dialdehyde intermediate.
Furthermore, this intermediate will need to be transformed in a series of steps, some of
which are enzyme-mediated, to generate aspernidine A (8). Although fungal SM
biosynthetic genes are often clustered in one region of the chromosome, we have identified
two examples in A. nidulans where the genes are located in at least two distinct genomic loci
and therefore we cannot exclude the possibility that additional genes in the genome are
involved in aspernidine A biosynthesis.22,23
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. LC-DAD-MS analysis of a control strain and strains carrying mpkAΔ, and both
mpkAΔ and pkfAΔ
(A) HPLC profiles of extracts of strains as detected by UV absorbance at 254 nm.
(B) Structures of compounds elucidated throughout this study. The compounds are as
follows: asperthecin, 1; austinol, 2; dehydroaustinol, 3; sterigmatocystin, 4; emericellin, 5;
shamixanthone, 6; epishamixanthone, 7; aspernidine A, 8; aspernidine C, 9; aspernidine D,
10; aspernidine E, 11.
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Figure 2. Boundary of the aspernidine A biosynthesis gene cluster
(A) Organization of genes surrounding the PKS pkfA involved in aspernidine A
biosynthesis in A. nidulans. Black open reading frames (ORFs) are genes involved in
aspernidine A biosynthesis while gray ORFs are genes not involved in aspernidine A
biosynthesis.
(B) HPLC profile of extracts of strains in the cluster as detected by UV absorption at 254
nm. Numbers on peaks correspond to the compounds shown in Figure 1B.
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Proposed biosynthetic pathway of aspernidine A.
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Table 1
Putative function of genes within the aspernidine A cluster.
Gene designation Putative function AspGD annotation Broad annotation
pkfB Cytochrome p450 AN3225 ANID_03225.1
pkfC Short chain dehydrogenase AN3226 ANID_03226.1
pkfD Hypothetical protein AN3227 ANID_03227.1
pkfE Prenyltransferase AN3228 ANID_03228.1
pkfF Choline dehydrogenase AN3229 ANID_03229.1
pkfA Polyketide synthase AN3230 ANID_03230.1
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